Price Chart

Profile

Opus Genetics, Inc. engages in the research and development of ophthalmic biopharmaceutical products. It focuses on developing and commercializing therapies for the treatment of several eye disorders. The company was founded by Mina Patel Soouch and Alan R. Meyer in February 2018 and is headquartered in Durham, NC.
URL http://opusgtx.com
Investor Relations URL https://ir.opusgtx.com/
HQ State/Province North Carolina
Sector Health Care
Industry Biotechnology
Next Earnings Release N/A
Last Earnings Release May. 08, 2025
Next Ex-Dividend Date N/A
Last Ex-Dividend Date N/A

Profile

Opus Genetics, Inc. engages in the research and development of ophthalmic biopharmaceutical products. It focuses on developing and commercializing therapies for the treatment of several eye disorders. The company was founded by Mina Patel Soouch and Alan R. Meyer in February 2018 and is headquartered in Durham, NC.
URL http://opusgtx.com
Investor Relations URL https://ir.opusgtx.com/
HQ State/Province North Carolina
Sector Health Care
Industry Biotechnology
Next Earnings Release N/A
Last Earnings Release May. 08, 2025
Next Ex-Dividend Date N/A
Last Ex-Dividend Date N/A